Pharmacy teams in all settings are ‘crucial’ to providing accessible health care, the Royal Pharmaceutical Society (RPS) has said in a new guide to tackling health inequalities.
The advice outlines ways in which pharmacy teams can improve access and outcomes for people suffering from healthcare inequality.
Claire Anderson, president of Royal Pharmaceutical Society said that ‘brilliant examples’ of pharmacy teams providing care to improve health inequalities ‘shine through’ in the paper.
She added that pharmacy could ‘now build on these examples of best practice, using this paper as a resource to support their development, to ensure no-one feels excluded or unable to access care.
‘As pharmacists, we need to think differently, proactively seek out people who may not be accessing our services, ensure we are welcoming and ultimately ensure that everyone can benefit from our support and care.’
The position paper, published today, shared the ‘stark reality’ of the ‘worsening picture’ of health inequalities since 2010, and follows a keynote speech from Sir Michael Marmot, Director of the Institute for Health Equity, at the RPS annual conference in November 2022.
It highlighted that life expectancy has stalled since 2010, which Sir Michael said was linked to social determinants of health.
For instance, in England, male mortality rates were nearly twice as high in the most deprived areas compared to the least, and there was a difference in life expectancy of around 10 years for women in the most deprived areas compared to the least.
Andrew Carruthers, chair of the RPS Scottish Pharmacy Board, said that tackling health inequalities was particularly important right now because of the increasing cost of living.
‘This paper aims to stimulate pharmacists’ thinking about how they provide care. It brings together resources that they can then dip into over time to make improvements with the ultimate aim of delivering accessible pharmaceutical care to everyone’, he said.
The RPS paper suggested that health inequalities could be influenced by factors such as:
- socio-economic factors like deprivation, power, education, language and employment
- geography (region, urban/rural, neighbourhood)
- protected characteristics (ethnicity, sex, age, disability, sexual orientation, gender reassignment, religion, pregnancy, being married or in a civil partnership)
- determinants of health (poverty, housing, education, community)
- groups vulnerable to being excluded (homeless, traveller communities, sex workers, drug dependence, modern slavery)
- a lack of diverse representation and cultural awareness in decision making and policy setting
- an active avoidance of engaging with health services (low self-worth, tolerating health conditions).
The RPS said that pharmacy teams should seek to understand their population served by their service in order to tackle health inequalities.
In addition to accessing demographic data, which may be available via NHS public health teams, pharmacy teams should also engage with people directly, the RPS recommended.
This could include approaching local community or faith groups, seeking views from patients or gaining insight from pharmacy staff members.
Pharmacy teams should then explore whether the patients accessing their service were representative of the population locally, or whether there were gaps in users or service provision, and seek to reach people not currently accessing health services.
The RPS added that this review may need to be conducted across settings including community, hospital, primary care and specialist services, and that a cross-setting approach would only work ‘if there are effective referral mechanisms in place and services are still accessible for patients’.
The paper also recommended that pharmacy teams seek to overcome their own unconscious bias, which may make patients hesitant to use services or drive them away, and ensure that patients from all backgrounds were informed about, and offered choice in how they access services.
And recent figures from NHS Digital found that the number of cancers diagnosed at stages 1 and 2 in the most deprived areas of England was significantly lower than those caught early in the least deprived areas, at 47% in the most deprived areas compared to 55% in the least.
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.